| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 27, 2017Patients with End-Stage Heart Failure Now Have New Options for Care
DUBLIN - September 27, 2017 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for its HeartWare(TM) HVAD(TM) System as a destination therapy for patients...
-
Sep 21, 2017New Study Designed to Assess Longer-Term Clinical Performance of Next-Generation Evolut PRO Transcatheter Aortic Valve Implantation (TAVI) System
DUBLIN - September 21, 2017 - Medtronic plc (NYSE: MDT) today announced a new post-market clinical study to evaluate its CoreValve(TM) Evolut(TM) PRO valve in everyday clinical practice. Studying...
-
Sep 18, 2017The Intellis Platform Includes the World's Smallest Implantable Spinal Cord Stimulator and Offers Personalized Pain Relief and Advanced Activity Tracking
DUBLIN - September 18, 2017 - Medtronic plc (NYSE:MDT) today announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain....
-
Sep 14, 2017Athletes from Five Continents Benefitting from Medical Technology Will Showcase Remarkable Spirit at the Medtronic Twin Cities Marathon and Medtronic TC 10 Mile Events This October
DUBLIN - September 14, 2017 - Long distance running is never easy. But for twenty long-distance runners participating in the Medtronic Twin Cities Marathon Weekend, just toeing the starting line...
-
Sep 13, 2017Five-Year, Real-World Data Demonstrate EVAR Outcomes with Endurant® II Stent Graft System Are Comparable in Both Male and Female Patients
DUBLIN and LAS VEGAS - September 13, 2017 - Medtronic plc (NYSE: MDT) today reported its Endurant® II abdominal aortic aneurysm (AAA) stent graft system continues to demonstrate long-term...
-
Sep 12, 2017New Platform to Offer Enhanced Visualization and Increased Efficiency for Surgery of the Sinuses and Skull Base
DUBLIN - September 12, 2017 - Medtronic plc (NYSE: MDT) today announced the global launch of the StealthStation(TM) ENT, a new surgical navigation system designed for surgeons treating conditions...
-
Sep 12, 2017Data Further Reinforce IN.PACT Admiral DCB as Frontline Option to Address Treatment Challenges in PAD
DUBLIN and LAS VEGAS - September 12, 2017 - Medtronic plc (NYSE: MDT) data announced today reinforce the durability and safety of the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in patients...
-
Sep 11, 2017
DUBLIN - September 11, 2017 - Medtronic plc (NYSE:MDT) announced today that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all models...
-
Sep 8, 2017Medtronic Announces Japanese Regulatory Approval for the IN.PACT(TM) Admiral(TM) Drug-Coated BalloonClinically-Proven, Durable, Consistent, and Safe Market-Leading DCB Poised to Improve Outcomes for PAD Patients in Japan
DUBLIN - September 8, 2017 - Medtronic plc (NYSE: MDT) today announced that the IN.PACT(TM)Admiral(TM) Drug-Coated Balloon (DCB) received approval from the Japanese Ministry of Health, Labour and...
-
Sep 7, 2017Company Marks a Decade on the North American Dow Jones Sustainability Index (DJSI)
DUBLIN - September 7, 2017 - Medtronic plc (NYSE: MDT) was recognized today as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability North...